Continuation of therapeutic dose heparin for critically ill patients with COVID-19.

ABSTRACT:

SUBMITTER: Bradbury CA 

PROVIDER: S-EPMC10231279 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature